Our Sustainability and ESG Goals

Dr. Reddy's integrated annual and sustainability report for the Fiscal Year 2024 is out. This edition acknowledges 40 years of Dr. Reddy's by taking you through our most significant milestones.

Our purpose "Good health can't wait" translates into three pillars with sustainability at the core

Access

To serve as many patients as possible across the world.

Affordability

Operational excellence and productivity to deliver care affordably to patients.

Patient-centric Innovation

Focused innovation to identify and address unmet needs of patients.

Our progress was recognized in our ascent to the Dow Jones Sustainability World Index, improved position in the S&P global sustainability yearbook, and gold medal status by Eco Vadis.

Sustainability is deeply embedded in our purpose and forms the core of our organization.

Our journey began with APIs in 1984, and we evolved from small molecules to large molecules and from APIs to finished formulations over the decades. Amidst this evolution, what has remained constant at the heart of our organization is a deep commitment to patients and the customers we serve through our core principles of collaboration and sustainability.

By the end of FY2024, we had served over 700 million patients and continue our endeavours to reach over 1.5 billion patients globally by 2030. This means almost one in every five people on this planet will use Dr. Reddy’s product or service. The health of people is strongly linked to the health of our planet. That's why our integrated report also shows how sustainability and business are strongly linked.

Our Sustainability Goals

Being committed to environmental stewardship

  • Reducing carbon emissions
    • 100% renewable power by 2030
    • Carbon neutrality in our direct operations (Scope 1 & Scope 2) by 2030
    • 12.5% reduction in indirect carbon emissions across our supply chain (Scope 3 emissions) by 2030
  • Reducing carbon emissions
    • 100% renewable power by 2030
    • Carbon neutrality in our direct operations (Scope 1 & Scope 2) by 2030
    • 12.5% reduction in indirect carbon emissions across our supply chain (Scope 3 emissions) by 2030

Making our products accessible and affordable for patients

  • Access
    • Serve 1.5 billion patients by 2030.
  • Affordability
    • 25% of our new-launches to be first-to-market by 2027.
  • Innovation
    • 3 innovative solutions to improve the standard of treatment every year from 2027.

Contributing to a fairer and more socially inclusive world

  • Equity, diversity, and inclusion
    • At least 35% women in senior leadership by 2030
    • Gender parity by 2035
    • Include at least 3% persons with disabilities (PwD) in our workforce by 2030.
    • 100% living wages for our on-premises extended workforce by 2025.

Enhancing trust with our stakeholders

  • Highest standards of compliance
    • Meet the highest standards on compliance and ethics backed by robust corporate governance ESG disclosures.
    • ESG Disclosures: Progressively enhance disclosure on our ESG progress to reach top quartile by 2025.
    • Strategic Suppliers: 100% strategic suppliers to be compliant with our ESG framework by 2030.
  • Affordability
  • Innovation

What we achieved in the past year:

kkjssjjkj
kkjssjjkj
kkjssjjkj
kkjssjjkj
kkjssjjkj
kkjssjjkj
kkjssjjkj